Skip to main content
. 2022 Aug 4;7(10):2242–2250. doi: 10.1016/j.ekir.2022.07.169

Figure 3.

Figure 3

Platelet aggregation by (a) the presence of CKD and (b) the presence and severity of CKD. Platelet aggregation percentage (y-axis) on aggregometry in response to agonist-dose combinations (x-axis) by study group. Floating bars show median and interquartile range. ∗indicates P < 0.05; ∗∗indicates P < 0.01. ADP, adenosine diphosphate; Epi, epinephrine; AA, arachidonic acid; ASAev, ex vivo aspirin; CKD, chronic kidney disease.